Chan-Wha Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chan-Wha Kim has a total of 261 co-authors. Here are the top co-authors by number of shared publications:
Hyun-Jung Kim
A College of Life Sciences and Biotechnology , Korea University , Seoul , Korea
14 shared publications- Jun-Seop Shin
Xenotransplantation Research Center, Seoul National University, College of Medicine, Seoul, Korea
10 shared publications Gi-Yeon Han
College of Life Sciences and Biotechnology, Korea University, Seoul 136-701, Korea
8 shared publicationsEun-Kyung Lee
College of Life Sciences and Biotechnology, Korea University, Seoul, Korea
6 shared publicationsHye Won Park
School of Life Sciences and Biotechnology, Korea University, Seoul 138-701, Korea, and Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139
6 shared publicationsHyun‐Jung Kim
Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, Korea
6 shared publications
Latest Publications
- Open Access
- 25 January 2021
- Published by Oxford University Press (OUP) in Journal of Industrial Microbiology and Biotechnology
- Vol. 48 (3-4)
Enhanced production of clavulanic acid by improving glycerol utilization using reporter-guided mutagenesis of an industrial Streptomyces clavuligerus strain
Clavulanic acid (CA) produced by Streptomyces clavuligerus is a clinically important β-lactamase inhibitor. It is known that glycerol utilization can significantly improve cell growth and CA production of S. clavuligerus. We found that the industrial CA-producing S. clavuligerus strain OR generated by random mutagenesis consumes less glycerol than the wild-type strain; we then developed a mutant strain in which the glycerol utilization operon is overexpressed, as compared to the parent OR strain, through iterative random mutagenesis and reporter-guided selection. The CA production of the resulting S. clavuligerus ORUN strain was increased by approximately 31.3% (5.21 ± 0.26 g/l) in a flask culture and 17.4% (6.11 ± 0.36 g/l) in a fermenter culture, as compared to that of the starting OR strain. These results confirmed the important role of glycerol utilization in CA production and demonstrated that reporter-guided mutant selection is an efficient method for further improvement of randomly mutagenized industrial strains.
- 25 January 2021
- Published by Oxford University Press (OUP) in Journal of Industrial Microbiology and Biotechnology
- Vol. 48 (3-4)
Open AccessEnhanced production of clavulanic acid by improving glycerol utilization using reporter-guided mutagenesis of an industrial Streptomyces clavuligerus strain
Clavulanic acid (CA) produced by Streptomyces clavuligerus is a clinically important β-lactamase inhibitor. It is known that glycerol utilization can significantly improve cell growth and CA production of S. clavuligerus. We found that the industrial CA-producing S. clavuligerus strain OR generated by random mutagenesis consumes less glycerol than the wild-type strain; we then developed a mutant strain in which the glycerol utilization operon is overexpressed, as compared to the parent OR strain, through iterative random mutagenesis and reporter-guided selection. The CA production of the resulting S. clavuligerus ORUN strain was increased by approximately 31.3% (5.21 ± 0.26 g/l) in a flask culture and 17.4% (6.11 ± 0.36 g/l) in a fermenter culture, as compared to that of the starting OR strain. These results confirmed the important role of glycerol utilization in CA production and demonstrated that reporter-guided mutant selection is an efficient method for further improvement of randomly mutagenized industrial strains.
- 29 September 2020
- Published by Wiley in Bulletin of the Korean Chemical Society
- Vol. 41 (10) , 1019-1026
Transgelin (TAGLN) Regulates IQGAP1 and Alters the Functions of Breast Cancer Cells
Several studies have been conducted on the transgelin (TAGLN) protein and its critical role in cancer biology. However, the regulation of this protein and the way in which this regulation is correlated with the functions of IQ motif‐containing GTPase‐activating protein 1 (IQGAP1) in MDA‐MB231 cells, remain unclear. We generated stable TAGLN‐knockdown and TAGLN‐overexpressing cells. These cells, along with their control counterparts, were cultured in the presence or absence of 17‐AAG. The different cell groups were then subjected to functional assays to assess proliferation, chemotaxis, and invasion. TAGLN regulation was found to affect the efficacy of 17‐AAG. The ability of TAGLN to influence the levels of IQGAP1 and its binding partners altered the critical functions of breast cancer cells. Therefore, the altered functionality of MDA‐MB‐231 cells, as a consequence of TAGLN regulation, is correlated with IQGAP1 signaling.
- 29 September 2020
- Published by Wiley in Bulletin of the Korean Chemical Society
- Vol. 41 (10) , 1019-1026
Transgelin (TAGLN) Regulates IQGAP1 and Alters the Functions of Breast Cancer Cells
Several studies have been conducted on the transgelin (TAGLN) protein and its critical role in cancer biology. However, the regulation of this protein and the way in which this regulation is correlated with the functions of IQ motif‐containing GTPase‐activating protein 1 (IQGAP1) in MDA‐MB231 cells, remain unclear. We generated stable TAGLN‐knockdown and TAGLN‐overexpressing cells. These cells, along with their control counterparts, were cultured in the presence or absence of 17‐AAG. The different cell groups were then subjected to functional assays to assess proliferation, chemotaxis, and invasion. TAGLN regulation was found to affect the efficacy of 17‐AAG. The ability of TAGLN to influence the levels of IQGAP1 and its binding partners altered the critical functions of breast cancer cells. Therefore, the altered functionality of MDA‐MB‐231 cells, as a consequence of TAGLN regulation, is correlated with IQGAP1 signaling.
- 1 August 2020
- Published by Wiley in Bulletin of the Korean Chemical Society
- Vol. 41 (8) , 812-823
Extremely Low-Frequency Electromagnetic Field Altered PPARγ and CCL2 Levels and Suppressed CD44+/CD24- Breast Cancer Cells Characteristics
- 1 August 2020
- Published by Wiley in Bulletin of the Korean Chemical Society
- Vol. 41 (8) , 812-823
Extremely Low-Frequency Electromagnetic Field Altered PPARγ and CCL2 Levels and Suppressed CD44+/CD24- Breast Cancer Cells Characteristics
- Open Access
- 15 May 2020
- Published by Springer Nature in AMB Express
- Vol. 10 (1) , 1-13
Rich production media as a platform for CHO cell line development
Recent cell culture media for mammalian cells can be abundantly formulated with nutrients supporting production, but such media can be limited to use in host cell culture, transfection, cell cloning, and cell growth under the low cell density conditions. In many cases, appropriate platform media are used for cell line development, and then replaced with rich media for production. In this study, we demonstrate rich chemically defined media for Chinese hamster ovary (CHO) cells that are suitable as basal media both for cell line development and for final production of culture process. Set up for transfection, semi-solid media optimization, mini-pool screening, and single cell cloning media development were performed, and final clones were obtained with higher productivity in fed-batch culture mode using rich formulated media comparing with lean formulated media. Developed methods may remove the requirements for cell adaptation to production media after cell line development, and relieve the clonality issues associated with changing the culture media. Furthermore, established methods have advantages over traditional approaches, including saving resources and decreasing the time and the effort required to optimize the production process.
- 15 May 2020
- Published by Springer Nature in AMB Express
- Vol. 10 (1) , 1-13
Open AccessRich production media as a platform for CHO cell line development
Recent cell culture media for mammalian cells can be abundantly formulated with nutrients supporting production, but such media can be limited to use in host cell culture, transfection, cell cloning, and cell growth under the low cell density conditions. In many cases, appropriate platform media are used for cell line development, and then replaced with rich media for production. In this study, we demonstrate rich chemically defined media for Chinese hamster ovary (CHO) cells that are suitable as basal media both for cell line development and for final production of culture process. Set up for transfection, semi-solid media optimization, mini-pool screening, and single cell cloning media development were performed, and final clones were obtained with higher productivity in fed-batch culture mode using rich formulated media comparing with lean formulated media. Developed methods may remove the requirements for cell adaptation to production media after cell line development, and relieve the clonality issues associated with changing the culture media. Furthermore, established methods have advantages over traditional approaches, including saving resources and decreasing the time and the effort required to optimize the production process.
- Open Access
- 30 April 2020
- Published by Springer Nature in Research Square
Rich production media as a platform for CHO cell line development
Recent cell culture media for mammalian cells can be abundantly formulated with nutrients supporting production, but such media can be limited to use in host cell culture, transfection, cell cloning, and cell growth under the low cell density conditions. In many cases, appropriate platform media are used for cell line development, and then replaced with rich media for production. In this study, we demonstrate rich chemically defined media for Chinese hamster ovary (CHO) cells that are suitable as basal media both for cell line development and for final production of culture process. Set up for transfection, semi-solid media optimization, mini-pool screening, and single cell cloning media development were performed, and final clones were obtained with higher productivity in fed-batch culture mode using rich formulated media comparing with lean formulated media. Developed methods may remove the requirements for cell adaptation to production media after cell line development, and relieve the clonality issues associated with changing the culture media. Furthermore, established methods have advantages over traditional approaches, including saving resources and decreasing the time and the effort required to optimize the production process.
- 30 April 2020
- Published by Springer Nature in Research Square
Open AccessRich production media as a platform for CHO cell line development
Recent cell culture media for mammalian cells can be abundantly formulated with nutrients supporting production, but such media can be limited to use in host cell culture, transfection, cell cloning, and cell growth under the low cell density conditions. In many cases, appropriate platform media are used for cell line development, and then replaced with rich media for production. In this study, we demonstrate rich chemically defined media for Chinese hamster ovary (CHO) cells that are suitable as basal media both for cell line development and for final production of culture process. Set up for transfection, semi-solid media optimization, mini-pool screening, and single cell cloning media development were performed, and final clones were obtained with higher productivity in fed-batch culture mode using rich formulated media comparing with lean formulated media. Developed methods may remove the requirements for cell adaptation to production media after cell line development, and relieve the clonality issues associated with changing the culture media. Furthermore, established methods have advantages over traditional approaches, including saving resources and decreasing the time and the effort required to optimize the production process.
- 7 November 2019
- Published by Wiley in Bulletin of the Korean Chemical Society
- Vol. 40 (12) , 1191-1201
Transgelin Depletion is Critical for the TGFβ1‐mediated Initiation of PLCγ1‐Cofilin‐driven Morphological and Migratory Changes in MDA‐MB‐231 Cells
The role of transgelin (TAGLN) in cancer has been discussed; however, the mechanisms underlying its regulation and correlation with MDA‐MB‐231 cell plasticity and migratory patterns remain unclear. We generated stable TAGLN‐knockdown MDA‐MB‐231 cells and treated them with phorbol 12‐myristate 13‐acetate or transforming growth factor (TGF)‐β. Chemotaxis, morphology, and invasion were assayed using three‐dimensional matrices to evaluate cytoskeletal remodeling and migratory changes. Wound healing assays were conducted using cell inserts. TAGLN knockdown cells exhibited altered morphology due to cytoskeletal remodeling, yet only untreated and TGFβ1‐treated cells exhibited enhanced migration. Untreated and TGFβ1‐treated TAGLN knockdown cells showed increased N‐WASP, ROCK1, and ROCK2 protein levels, which induce cytoskeletal remodeling. Evaluating phospholipase Cγ1 (PLCγ1)‐cofilin signaling‐related proteins revealed that only TGFβ1‐treated TAGLN knockdown cells were influenced by PLCγ1‐cofilin signaling. Taken together, TAGLN knockdown is necessary for the TGFβ1‐mediated activation of PLCγ1‐cofilin pathway‐driven amoeboid morphology and enhanced migratory properties in MDA‐MB‐231 cells.
- 7 November 2019
- Published by Wiley in Bulletin of the Korean Chemical Society
- Vol. 40 (12) , 1191-1201
Transgelin Depletion is Critical for the TGFβ1‐mediated Initiation of PLCγ1‐Cofilin‐driven Morphological and Migratory Changes in MDA‐MB‐231 Cells
The role of transgelin (TAGLN) in cancer has been discussed; however, the mechanisms underlying its regulation and correlation with MDA‐MB‐231 cell plasticity and migratory patterns remain unclear. We generated stable TAGLN‐knockdown MDA‐MB‐231 cells and treated them with phorbol 12‐myristate 13‐acetate or transforming growth factor (TGF)‐β. Chemotaxis, morphology, and invasion were assayed using three‐dimensional matrices to evaluate cytoskeletal remodeling and migratory changes. Wound healing assays were conducted using cell inserts. TAGLN knockdown cells exhibited altered morphology due to cytoskeletal remodeling, yet only untreated and TGFβ1‐treated cells exhibited enhanced migration. Untreated and TGFβ1‐treated TAGLN knockdown cells showed increased N‐WASP, ROCK1, and ROCK2 protein levels, which induce cytoskeletal remodeling. Evaluating phospholipase Cγ1 (PLCγ1)‐cofilin signaling‐related proteins revealed that only TGFβ1‐treated TAGLN knockdown cells were influenced by PLCγ1‐cofilin signaling. Taken together, TAGLN knockdown is necessary for the TGFβ1‐mediated activation of PLCγ1‐cofilin pathway‐driven amoeboid morphology and enhanced migratory properties in MDA‐MB‐231 cells.
- 10 October 2019
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 84 (2) , 256-267
Mesenchymal stem cells co-cultured with colorectal cancer cells showed increased invasive and proliferative abilities due to its altered p53/TGF-β1 levels
Signaling between cancer cells, their neighboring cells, and mesenchymal stem cells (MSCs) forms the tumor microenvironment. The complex heterogeneity of this microenvironment varies depending on the tumor type and its origins. However, most of the existing cancer-based studies have focused on cancer cells. In this study, we used a direct co-culture system (cross-talk signaling) to induce cross-interaction between cancer cells and mesenchymal stem cells. This induced deformation of MSCs. MSCs showed a diminished ability to maintain homeostasis. In particular, increase in the invasion ability of MSCs by TGF-β1 and decrease in p53, which plays a key role in cancer development, is an important discovery. It can thus be deduced that blocking these changes can effectively inhibit metastatic colorectal cancer. In conclusion, understanding the interactions and changes in MSCs associated with cancer will help develop novel therapeutic strategies for cancer. Tumor cells recruit MSCs around the tumor cells and improve their invasion ability. This is similar to cancer cells and the aberrant alteration facilitates tumor development and induces the tumor surroundings to become more malignant.
- 10 October 2019
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 84 (2) , 256-267
Mesenchymal stem cells co-cultured with colorectal cancer cells showed increased invasive and proliferative abilities due to its altered p53/TGF-β1 levels
Signaling between cancer cells, their neighboring cells, and mesenchymal stem cells (MSCs) forms the tumor microenvironment. The complex heterogeneity of this microenvironment varies depending on the tumor type and its origins. However, most of the existing cancer-based studies have focused on cancer cells. In this study, we used a direct co-culture system (cross-talk signaling) to induce cross-interaction between cancer cells and mesenchymal stem cells. This induced deformation of MSCs. MSCs showed a diminished ability to maintain homeostasis. In particular, increase in the invasion ability of MSCs by TGF-β1 and decrease in p53, which plays a key role in cancer development, is an important discovery. It can thus be deduced that blocking these changes can effectively inhibit metastatic colorectal cancer. In conclusion, understanding the interactions and changes in MSCs associated with cancer will help develop novel therapeutic strategies for cancer. Tumor cells recruit MSCs around the tumor cells and improve their invasion ability. This is similar to cancer cells and the aberrant alteration facilitates tumor development and induces the tumor surroundings to become more malignant.
- 30 August 2019
- Published by Wiley in Bulletin of the Korean Chemical Society
- Vol. 40 (10) , 1002-1012
Applying the Quality by Design to Robust Optimization and Design Space Define for Erythropoietin Cell Culture Process
This study is aimed to identify the process characterization of the cell culture of the biopharmaceutical erythropoietin alpha. In biopharmaceutical manufacturing, ensuring safety and efficacy should always be target qualities. The “quality by design” initiative provides guidance on pharmaceutical development to facilitate design of products and processes that maximizes the product′s efficacy and safety profile while enhancing product manufacturability. Fundamental to this approach is an understanding of the relationship between the quality attributes of the product and their impact on safety and efficacy. The DoE approach focuses on quality‐by‐design (QbD). To implement QbD, we report on a case regarding the production of erythropoietin alpha using cultured Chinese hamster ovary cells. Changes in the four critical process parameters (CPPs) of RPM, pH, dissolved oxygen, and temperature were evaluated. To evaluate the DoE, the three CQAs of Z‐value (N‐glycan score), host cell protein content, and erythropoietin alpha concentration (titer) were monitored and analyzed. Multivariate regression analysis between CPPs and CQAs were used to identify the design space needed to satisfy the targeted CQAs. We used QbD techniques and found optimal conditions for the cell culture process of erythropoietin alpha. Monte Carlo simulation was used under the optimized conditions and the set points were verified. As a result, it was confirmed that the optimal operational range was RPM 191.1–209.0, bioreactor temperature 32–34 °C, pH 7.0–7.2, and dissolved oxygen 24.9–35.1. This scientific understanding facilitates establishment of an expanded design space. In these situations, opportunities exist to develop more flexible regulatory approaches.
- 30 August 2019
- Published by Wiley in Bulletin of the Korean Chemical Society
- Vol. 40 (10) , 1002-1012
Applying the Quality by Design to Robust Optimization and Design Space Define for Erythropoietin Cell Culture Process
This study is aimed to identify the process characterization of the cell culture of the biopharmaceutical erythropoietin alpha. In biopharmaceutical manufacturing, ensuring safety and efficacy should always be target qualities. The “quality by design” initiative provides guidance on pharmaceutical development to facilitate design of products and processes that maximizes the product′s efficacy and safety profile while enhancing product manufacturability. Fundamental to this approach is an understanding of the relationship between the quality attributes of the product and their impact on safety and efficacy. The DoE approach focuses on quality‐by‐design (QbD). To implement QbD, we report on a case regarding the production of erythropoietin alpha using cultured Chinese hamster ovary cells. Changes in the four critical process parameters (CPPs) of RPM, pH, dissolved oxygen, and temperature were evaluated. To evaluate the DoE, the three CQAs of Z‐value (N‐glycan score), host cell protein content, and erythropoietin alpha concentration (titer) were monitored and analyzed. Multivariate regression analysis between CPPs and CQAs were used to identify the design space needed to satisfy the targeted CQAs. We used QbD techniques and found optimal conditions for the cell culture process of erythropoietin alpha. Monte Carlo simulation was used under the optimized conditions and the set points were verified. As a result, it was confirmed that the optimal operational range was RPM 191.1–209.0, bioreactor temperature 32–34 °C, pH 7.0–7.2, and dissolved oxygen 24.9–35.1. This scientific understanding facilitates establishment of an expanded design space. In these situations, opportunities exist to develop more flexible regulatory approaches.
- 20 May 2019
- Published by Wiley in Bulletin of the Korean Chemical Society
- Vol. 40 (7) , 623-633
Application of the Quality‐by‐Design (QbD) Approach for Erythropoietin Alpha Purification
This study was aimed at process characterization and improving quality of purification of erythropoietin α, a biopharmaceutical agent. In biopharmaceutical manufacturing, quality should always be targeted to ensure safety and efficacy. Design‐of‐experiments–based approaches have been explored to rapidly and efficiently achieve an optimized yield and an increased understanding of a product and process variables affecting the product's critical quality attributes in the biopharmaceutical industry; this system is known as the quality‐by‐design approach. Changes in three critical process parameters—buffer pH, flow rate, and loading amount—were evaluated. Process characterization was conducted on a scaled‐down model previously validated by comparison with data from a large‐scale production facility. Seven critical quality attributes—relative aggregate content, host cell protein, host cell deoxynucleotides, endotoxin, Z‐value (N‐glycan score), relative content of charge isomers, and step yield—were analyzed. Multivariate regression analysis was performed to establish statistical prediction models for performance indicators and quality attributes; accordingly, we constructed contour plots and conducted a Monte Carlo simulation to clarify the design space. As a result of the optimization analysis of the purification process, it was confirmed that proven acceptance ranges were optimized as follows: loading amount (mg/mL) 0.4–4.0, buffer pH 7.0–8.0, and flow rate (mL/min) 0.5–1.6.
- 20 May 2019
- Published by Wiley in Bulletin of the Korean Chemical Society
- Vol. 40 (7) , 623-633
Application of the Quality‐by‐Design (QbD) Approach for Erythropoietin Alpha Purification
This study was aimed at process characterization and improving quality of purification of erythropoietin α, a biopharmaceutical agent. In biopharmaceutical manufacturing, quality should always be targeted to ensure safety and efficacy. Design‐of‐experiments–based approaches have been explored to rapidly and efficiently achieve an optimized yield and an increased understanding of a product and process variables affecting the product's critical quality attributes in the biopharmaceutical industry; this system is known as the quality‐by‐design approach. Changes in three critical process parameters—buffer pH, flow rate, and loading amount—were evaluated. Process characterization was conducted on a scaled‐down model previously validated by comparison with data from a large‐scale production facility. Seven critical quality attributes—relative aggregate content, host cell protein, host cell deoxynucleotides, endotoxin, Z‐value (N‐glycan score), relative content of charge isomers, and step yield—were analyzed. Multivariate regression analysis was performed to establish statistical prediction models for performance indicators and quality attributes; accordingly, we constructed contour plots and conducted a Monte Carlo simulation to clarify the design space. As a result of the optimization analysis of the purification process, it was confirmed that proven acceptance ranges were optimized as follows: loading amount (mg/mL) 0.4–4.0, buffer pH 7.0–8.0, and flow rate (mL/min) 0.5–1.6.